EnWave Signs Technology Evaluation and License Option Agreement with American Multinational Food Company
(firmenpresse) - EnWave Signs Technology Evaluation and License Option Agreement with American Multinational Food Company
Vancouver, B.C., August 11, 2017
EnWave Corporation (TSX-V:ENW | FSE:E4U) (EnWave, or the "Company") today announced that, the Company has signed a Technology Evaluation and License Option Agreement (the Agreement) with a major American multinational food company (the Partner). The Partner is an international leader in the meat and prepared food industries.
The Agreement enables the Partner to evaluate Radiant Energy Vacuum (REV) technology as a viable option to process several of its current and potential commercial offerings. The Agreement between EnWave and the Partner allows for the rental of pilot-scale REV machinery for a period of up to six months. EnWave has granted the Partner an option to exclusively license this technology for specific products and territories should the outcome of the evaluation be successful. All other terms of the Agreement are confidential.
About EnWave
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (REV) - an innovative, proprietary method for the precise dehydration of organic materials. REV technologys commercial viability has been demonstrated and is growing rapidly across several market verticals in the food and pharmaceutical sectors. EnWaves strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV technology. The company has signed twenty-two royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.
EnWave has introduced REV as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV platforms:
1.-nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
2.-powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
3.-quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
EnWave Corporation
Dr. Tim Durance
President & CEO
Suite 425 - 744 West Hastings St., Vancouver, B.C., CANADA V6C 1A5
Tel (604) 806-6110 Fax (604) 806-6112
TSX Venture Exchange trading symbol: ENW
www.enwave.net
For further information:
John Budreski, Executive Chairman at +1 (416) 930-0914
E-mail: jbudreski(at)enwave.net
Brent Charleton, Senior Vice President, Business Development at +1 (778) 378-9616
E-mail: bcharleton(at)enwave.net
Jeremy Hellman, Senior Associate, The Equity Group at +1 (212) 836-9626
E-mail: jhellman(at)equityny.com
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Leseranfragen:
EnWave Corporation ist ein in Vancouver ansässiges Technologieunternehmen das kommerzielle Applikationen für ihre geschützte Radiant Energy Vacuum (REV™) Trocknungstechnologie anbietet.
" alt="MAG Silver Reports Second Quarter Financial ResultsDatum: 14.08.2017 - 07:37 Uhr
Sprache: Deutsch
News-ID 556309
Anzahl Zeichen: 5171
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 452 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"EnWave Signs Technology Evaluation and License Option Agreement with American Multinational Food Company
"
steht unter der journalistisch-redaktionellen Verantwortung von
EnWave Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
